Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
VEL | Ann: Removal from official list | 27/02/19 | 0 | 782 | |||
|
|||||||
VEL | Ann: Results of Meeting | 14:32 | 0 | 566 | |||
|
|||||||
VEL | Ann: Chairman's Address to Shareholders | 12:31 | 0 | 789 | |||
|
|||||||
VEL | Ann: Annual Report to shareholders | 09:21 | 0 | 885 | |||
|
|||||||
VEL | Ann: Suspension from Official Quotation | 05/09/18 | 0 | 764 | |||
|
|||||||
VEL | Ann: Correction record date | 04/09/18 | 0 | 769 | |||
|
|||||||
VEL | Ann: Letter to Shareholders | 03/09/18 | 0 | 709 | |||
|
|||||||
VEL | Ann: Change in substantial holding | 03/09/18 | 0 | 665 | |||
|
See All Discussions